Regular Article
Identification and Structure of the Nerve Growth Factor Binding Site on TrkA

https://doi.org/10.1006/bbrc.2001.4462Get rights and content

Abstract

Nerve growth factor (NGF) is involved in the development and maintenance of the nervous system and has been implicated as a possible therapeutic target molecule in a number of neurodegenerative diseases, especially Alzheimer's disease. NGF binds with high affinity to the extracellular region of a tyrosine kinase receptor, TrkA, which comprises three leucine-rich motifs (LRMs), flanked by two cysteine-rich clusters, followed by two immunoglobulin-like (Ig-like) domains. We have expressed the second Ig-like domain as a recombinant protein in E. coli and demonstrate that NGF binds to this domain with similar affinity to the native receptor. This domain (TrkAIg2) has the ability to sequester NGF in vitro, preventing NGF-induced neurite outgrowth, and in vivo, inhibiting NGF-induced plasma extravasation. We also present the three-dimensional structure of the TrkAIg2 domain in a new crystal form, refined to 2.0 Å resolution.

References (54)

  • G.N. Ramachandran et al.

    Conformation of polypeptides and proteins

    Adv. Protein Chem.

    (1968)
  • G.J. Kleywegt et al.

    Phi/psi-chology: Rachandran revisited

    Structure

    (1996)
  • S.J. Allen et al.

    Cloning of a noncatalytic form of human trkb and distribution of messenger-RNA for trkb in human brain

    Neuroscience

    (1994)
  • J.T. Yang et al.

    Calculation of protein conformation from circular-dichroism

    Methods Enzymol.

    (1986)
  • D.M. Loeb et al.

    The trk protooncogene rescues NGF responsiveness in mutant NGF-nonresponsive pc12 cell-lines

    Cell

    (1991)
  • M.V. Hayes et al.

    Engineered assembly of intertwined oligomers of an immunoglobulin chain

    J. Mol. Biol.

    (1999)
  • U. Otten et al.

    Nerve growth-factor induces plasma extravasation in rat skin

    Eur. J. Pharmacol.

    (1984)
  • H. Hatanaka et al.

    Developmental-change in the nerve growth-factor action from induction of choline-acetyltransferase to promotion of cell-survival in cultured basal forebrain cholinergic neurons from postnatal rats

    Dev. Brain Res.

    (1988)
  • E.O. Junard et al.

    Long-term administration of mouse nerve growth-factor to adult-rats with partial lesions of the cholinergic septohippocampal pathway

    Exp. Neurol.

    (1990)
  • C.N. Montero et al.

    Intraventricular nerve growth-factor administration prevents lesion-induced loss of septal cholinergic neurons in aging rats

    Neurobiol. Aging

    (1989)
  • N. Ninkina et al.

    TrkB variants with deletions in the leucine-rich motifs of the extracellular domain

    J. Biol. Chem.

    (1997)
  • J.I.S. MacDonald et al.

    Deletions in the extracellular domain of rat trkA lead to an altered differentiative phenotype in neurotrophin responsive cells

    Mol. Cell. Neurosci.

    (1996)
  • A. Rodriguez-Tebar et al.

    Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth-factor and brain-derived neurotrophic factor

    EMBO J.

    (1992)
  • D. Martin-Zanca et al.

    Molecular and biochemical-characterization of the human trk proto-oncogene

    Mol. Cell. Biol.

    (1989)
  • R. Urfer et al.

    The binding epitopes of neurotrophin-3 to its receptors trkc and gp75 and the design of a multifunctional human neurotrophin

    EMBO J.

    (1994)
  • R. Schneider et al.

    A novel modular mosaic of cell-adhesion motifs in the extracellular domains of the neurogenic trk and trkb tyrosine kinase receptors

    Oncogene

    (1991)
  • Cited by (38)

    • 2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma

      2019, European Journal of Medicinal Chemistry
      Citation Excerpt :

      In the final stage of LigPrep, compounds were minimized with OPLS-2001 Force field [75]. The Human nerve growth receptor structure with PDBID 1HE7 (Resolution- 2 Å) is downloaded from Protein Data Bank [76]. The protein structure was prepared using the ‘Protein Preparation Wizard’ of the Schrödinger suite (Schrödinger, LLC, New York, NY, 2009).

    • Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain

      2010, Pain
      Citation Excerpt :

      The sTNFR consisted of 2 murine p75 receptors fused to murine IgG2a and was produced as previously described [27]). The binding domain of the tyrosine kinase receptor (TrkAd5) has been shown to be the only domain of the TrkA receptor required for binding to NGF [30]. This small (13 kDa) soluble receptor domain is able to bind NGF with high affinity and issequester NGF, blocking its action on both receptors [37].

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: 0117 928 3137. E-mail [email protected].

    View full text